Teva Pharmaceutical Indus... (TEVA)
NYSE: TEVA
· Real-Time Price · USD
17.68
0.14 (0.80%)
At close: Aug 15, 2025, 11:59 AM
Teva Pharmaceutical Industries Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.16B | 1.7B | 3.3B | 3.32B | 2.26B | 2.99B | 3.23B | 2.25B | 2.67B | 2.14B | 2.8B | 2.23B | 2.06B | 2.17B | 2.17B | 2.04B | 2.44B | 1.74B |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 8M | n/a | 9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 471M | 464M | 462M | 458M | 434M | 471M | 462M | 477M | 434M | 450M | 441M | 438M | 454M | 472M | 515M | 518M | 530M | 524M |
Receivables | 3.56B | 3.38B | 3.06B | 3.46B | 3.77B | 3.46B | 3.41B | 3.38B | 3.54B | 3.44B | 3.7B | 3.73B | 4.47B | 4.25B | 4.53B | 4.05B | 4.49B | 4.57B |
Inventory | 3.5B | 3.25B | 3.01B | 3.96B | 3.93B | 3.95B | 4.02B | 4.05B | 4.11B | 4.12B | 3.83B | 3.86B | 4.05B | 4.01B | 3.82B | 4.17B | 4.36B | 4.41B |
Other Current Assets | 3.4B | 2.18B | 2.18B | 447M | 585M | 565M | 575M | 572M | 543M | 552M | 559M | 594M | 534M | 947M | 986M | 830M | 514M | 738M |
Total Current Assets | 12.62B | 11.53B | 12.55B | 12.31B | 11.63B | 12.3B | 12.48B | 11.43B | 12.09B | 11.5B | 12.05B | 11.45B | 12.16B | 12.45B | 12.57B | 12.15B | 12.82B | 12.4B |
Property-Plant & Equipment | 5.17B | 4.99B | 4.95B | 6.04B | 5.93B | 5.98B | 6.15B | 6.03B | 6.13B | 6.17B | 6.16B | 5.99B | 6.18B | 6.4B | 6.48B | 6.55B | 6.66B | 6.64B |
Goodwill & Intangibles | 20.09B | 19.67B | 19.57B | 20.88B | 21.34B | 22.06B | 22.56B | 22.41B | 22.86B | 23.76B | 23.9B | 24.83B | 25.54B | 27.1B | 27.51B | 28.01B | 28.54B | 28.75B |
Total Long-Term Assets | 27.51B | 26.89B | 26.77B | 29.44B | 29.71B | 30.48B | 30.99B | 30.66B | 31.01B | 31.96B | 31.95B | 32.8B | 33.77B | 34.61B | 35.09B | 35.7B | 36.37B | 36.6B |
Total Assets | 40.13B | 38.41B | 39.33B | 41.76B | 41.34B | 42.77B | 43.48B | 42.09B | 43.09B | 43.46B | 44.01B | 44.25B | 45.93B | 47.06B | 47.67B | 47.85B | 49.2B | 49B |
Account Payables | 2.5B | 2.29B | 2.2B | 2.37B | 2.37B | 2.44B | 2.6B | 2.28B | 2.51B | 2.38B | 1.89B | 1.64B | 1.9B | 1.75B | 1.69B | 1.51B | 1.55B | 1.69B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 6.92B | 6.62B | 6.38B | n/a | 1.45B | 1.55B | 6.46B | n/a | 596M | 6.83B | 6.77B | 6.96B |
Short-Term Debt | 464M | 421M | 1.78B | 2.58B | 2.09B | 3.06B | 1.67B | 1.48B | 1.98B | 1.02B | 2.11B | 2.77B | 1.72B | 2.08B | 1.43B | 2.71B | 3.53B | 2.7B |
Other Current Liabilities | 8.9B | 5.49B | 8.81B | 8.23B | 8.09B | 7.8B | 7.26B | 7.11B | 6.9B | 6.58B | 2.42B | 6.63B | 6.91B | 7.3B | 7.24B | 7.05B | 7.1B | 7.17B |
Total Current Liabilities | 11.86B | 11.16B | 12.8B | 13.8B | 13.04B | 13.79B | 12.25B | 11.39B | 11.84B | 10.41B | 11.47B | 11.53B | 11B | 11.61B | 11.03B | 11.82B | 12.69B | 12.09B |
Long-Term Debt | 17.06B | 16.23B | 16B | 16.4B | 16.55B | 16.58B | 18.16B | 18.5B | 18.7B | 19.67B | 19.1B | 18.5B | 20.36B | 20.84B | 21.62B | 21.04B | 21.6B | 22.29B |
Other Long-Term Liabilities | n/a | 4.01B | 4.03B | 4.88B | 4.36B | 3.99B | 4.02B | 3.82B | 3.97B | 3.87B | 3.3B | 3.85B | 3.84B | 3.29B | 2.58B | 2.2B | 2.21B | 2.22B |
Total Long-Term Liabilities | 17.5B | 20.99B | 20.81B | 21.58B | 21.74B | 21.44B | 23.11B | 23.18B | 23.54B | 24.43B | 23.85B | 23.2B | 25.11B | 25.19B | 25.39B | 24.57B | 25.19B | 25.94B |
Total Liabilities | 21.44B | 32.15B | 33.61B | 35.37B | 34.77B | 35.23B | 35.35B | 34.58B | 35.39B | 34.84B | 35.31B | 34.73B | 36.1B | 36.8B | 36.42B | 36.4B | 37.88B | 38.03B |
Total Debt | 17.52B | 16.94B | 18.08B | 19.27B | 18.92B | 19.94B | 20.15B | 20.3B | 21.02B | 21.04B | 21.56B | 21.62B | 22.45B | 23.31B | 23.46B | 24.17B | 25.58B | 25.43B |
Common Stock | n/a | 58M | 58M | 58M | 58M | 58M | 57M | 57M | 57M | 57M | 57M | 57M | 57M | 57M | 57M | 57M | 57M | 57M |
Retained Earnings | n/a | -14.96B | -15.17B | -14.96B | -14.52B | -13.67B | -13.53B | -13.87B | -13.95B | -13.09B | -12.88B | -11.66B | -11.72B | -11.48B | -10.53B | -10.37B | -10.66B | -10.87B |
Comprehensive Income | n/a | -2.67B | -3.15B | -2.77B | -2.88B | -2.77B | -2.7B | -2.91B | -2.68B | -2.7B | -2.84B | -3.15B | -2.8B | -2.69B | -2.68B | -2.62B | -2.45B | -2.53B |
Shareholders Equity | 6.83B | 6.26B | 5.37B | 6.07B | 6.36B | 7.28B | 7.51B | 6.93B | 7.05B | 7.86B | 7.9B | 8.77B | 9.04B | 9.34B | 10.28B | 10.47B | 10.32B | 10B |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | 8M | n/a | 9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |